• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24133 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2007     HAYES, Inc. Plethysmography for chronic venous insufficiency
2006     HAYES, Inc. Plethysmography for diagnosis of deep vein thrombosis of the legs
2016     HAYES, Inc. PleurX peritoneal catheter for home management of malignant ascites
2007     HAYES, Inc. Pleurx pleural catheter (Denver Biomedical Inc.) for home management of malignant pleural effusions
2022     National Institute for Health and Care Excellence (NICE) PLGF-based testing to help diagnose suspected preterm pre-eclampsia. NICE diagnostics guidance 49
2015     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) for relapsed and refractory multiple myeloma – fourth line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) in combination with dexamethasone for multiple myeloma – third line
2013     HAYES, Inc. PLP1-related disorders (including pelizaeus-merzbacher disease [PMD])
2021     National Institute for Health and Care Excellence (NICE) Plus Sutures for preventing surgical site infection. NICE medical technologies guidance 59
2011     HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following hip surgery
2011     HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2013     HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2001     Agency for Healthcare Research and Quality (AHRQ) Pneumatic compression for treatment of chronic venous insufficiency and venous ulcers
2009     HAYES, Inc. Pneumatic compression therapy for mastectomy-related lymphedema
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Pneumatic compression therapy on venous insufficiency
2014     Malaysian Health Technology Assessment (MaHTAS) Pneumococcal conjugate vaccine for children below five years old
2003     HAYES, Inc. Pneumococcal conjugate vaccine for young children
2025     Agency for Care Effectiveness (ACE) Pneumococcal conjugate vaccines (15-valent and 20-valent) for the prevention of pneumococcal disease in adults
2020     Malaysian Health Technology Assessment (MaHTAS) Pneumococcal vaccination with 23-valent polysaccharide vaccine (PPV23) for elderly
2003     Health Council of the Netherlands Gezondheidsraad (GR) Pneumococcal vaccine in elderly adults and risk groups
2022     Penn Medicine Center for Evidence-based Practice (CEP) Pneumocystis jirovecii pneumonia (PJP) prophylaxis
2020     National Institute for Health and Care Excellence (NICE) PneuX to prevent ventilator-associated pneumonia. NICE medical technologies guidance 48
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2020     Health Technology Wales (HTW) Point of care haemolysis detection in blood samples that may be deemed unfit for laboratory analysis
2006     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Point of care testing - systematic review, expert panel
2001     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Point of care testing bed side system - systematic review, primary research, expert panel, working group
1998     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Point of care testing bedside system (systematic review, primary research, expert panel, working group)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing compared to laboratory testing for the assessment of white blood cell counts and differentials: a review of the clinical effectiveness, diagnostic precision and accuracy, cost-effectiveness, and guidelines
2008     Adelaide Health Technology Assessment (AHTA) Point of care testing for Coeliac disease
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing for human chorionic gonadotropin, creatinine, and blood urea nitrogen: cost-effectiveness
2008     Penn Medicine Center for Evidence-based Practice (CEP) Point of care testing for monitoring anticoagulation therapy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing for streptococcal sore throat: a review of diagnostic accuracy, cost-effectiveness, and guidelines
2005     Agency for Healthcare Research and Quality (AHRQ) Point of care testing of hemoglobin A1C
2006     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Point Of Care Testing System
2024     Austrian Institute for Health Technology Assessment (AIHTA) Point of care tests (POCT): D-dimer and troponin (Update 2024)
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care ultrasound for guided central venous catheter insertion
2020     Penn Medicine Center for Evidence-based Practice (CEP) Point of care vascular ultrasound
2018     Penn Medicine Center for Evidence-based Practice (CEP) Point-of Care Ultrasound for Acute Respiratory Distress
2019     National Institute for Health and Care Excellence (NICE) Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. NICE diagnostics guidance 37
2020     NIHR Health Technology Assessment programme Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2025     Swiss Federal Office of Public Health (FOPH) Point-of-care diagnostic tests
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: a budget impact analysis
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: an evidence-based analysis
2014     Health Quality Ontario (HQO) Point-of-care hemoglobin A1c testing: OHTAC recommendation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care HIV testing: a review of the clinical and cost-effectiveness and diagnostic accuracy
2008     Adelaide Health Technology Assessment (AHTA) Point-of-care influenza diagnostic tests
2007     Adelaide Health Technology Assessment (AHTA) Point-of-care influenza tests
2009     Medical Advisory Secretariat (MAS) Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness
2012     Malaysian Health Technology Assessment (MaHTAS) Point-Of-Care test for Chlamydia
2007     HAYES, Inc. Point-of-care testing for glycated hemoglobin (A1c) using A1cNow (Metrika Inc.) for management of diabetes
2011     HAYES, Inc. Point-of-care testing for glycated hemoglobin (A1c) using Bayer A1CNow+ multi-test A1C system (Bayer HealthCare LLC) for management of diabetes
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Point-of-care testing in the private sector
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care testing: a review of systematic reviews on testing accuracy and cost-effectiveness
2019     European Network for Health Technology Assessment (EUnetHTA) Point-of-care tests (POCT): D-dimer and troponin
2024     NIHR Health Technology Assessment programme Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model
2010     HAYES, Inc. Point-of-care thromboelastography and platelet function testing for management of perioperative transfusion therapy in cardiopulmonary bypass patients
2016     Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care troponin testing in patients with symptoms suggestive of acute coronary syndrome: a health technology assessment
2021     Health Technology Wales (HTW) Point-of-care ultrasound to diagnose gallstone disease
1995     University HealthSystem Consortium (UHC) Point-of-care whole-blood clinical analyzers
2024     Agency for Care Effectiveness (ACE) Polatuzumab vedotin for previously untreated diffuse large B-cell lymphoma
2022     Agency for Care Effectiveness (ACE) Polatuzumab vedotin for treating relapsed or refractory diffuse large B-cell lymphoma
2023     National Institute for Health and Care Excellence (NICE) Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma. NICE technology appraisal guidance 874
2020     European Network for Health Technology Assessment (EUnetHTA) Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for haematopoietic stem cell transplant
2020     National Institute for Health and Care Excellence (NICE) Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma. NICE technology appraisal guidance 649
2004     Adelaide Health Technology Assessment (AHTA) PoleStar (TM) N-10: intraoperative MRI for neurosurgical procedures
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
1999     TNO Policy documents for the home care program
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Policy guidance on hip protectors in long-term care
2016     HAYES, Inc. Polidocanol endovenous microfoam (Varithena) 1% for treatment of varicose veins
2022     Agency for Care Effectiveness (ACE) Poly (ADP-ribose) polymerase inhibitors for treating BRCA-mutated, HER2-negative advanced breast cancer
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Polyclonal intravenous immunoglobulin in patients with immune thrombocytopenic purpura: clinical systematic review
2009     HAYES, Inc. Polyetheretherketone (PEEK) interbody cages for spinal fusion
2003     Adelaide Health Technology Assessment (AHTA) Polyheme (R) and hemopure (R), blood substitute products: for the provision of emergency, short-term transfusion to trauma patients
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Polylactic-glycolic acid absorbable synthetic suture (Pgla) plus antibacterial: a systematic review
1995     University HealthSystem Consortium (UHC) Polymerase chain reaction
2007     HAYES, Inc. Polymerase chain reaction (PCR) molecular testing for diagnosis of group B streptococcal infection in newborns
2007     HAYES, Inc. Polymerase chain reaction (PCR)-based assays For methicillin-resistant staphylococcus aureus (MRSA) surveillance testing
2010     HAYES, Inc. Polymerase Chain Reaction (PCR)-based assays for rapid diagnosis of clostridium difficile in hospitalized patients
2003     Medical Services Advisory Committee (MSAC) Polymerase chain reaction in the diagnosis and monitoring of patients with AML1-ETO and CBF beta-MYH11 gene rearrangement in acute myeloid leukaemia
2004     Medical Services Advisory Committee (MSAC) Polymerase chain reaction in the diagnosis and monitoring of patients with BCR-ABL gene rearrangement in acute lymphoblastic leukaemia
2003     Medical Services Advisory Committee (MSAC) Polymerase chain reaction in the diagnosis and monitoring of patients with BCR-ABL gene rearrangement in chronic myeloid leukaemia
2003     Medical Services Advisory Committee (MSAC) Polymerase chain reaction in the diagnosis and monitoring of patients with PML-RAR alpha and PLZF-RAR alpha gene rearrangement in acute promyelocytic leukaemia
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Polymerase chain reaction tests for methicillin-resistant staphylococcus aureus in hospitalized patients: clinical and cost-effectiveness analyses
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Polypharmacological treatment of type 2 diabetes in daily clinical practice - primary research, conference
2006     Medical Advisory Secretariat (MAS) Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis
2019     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 1: A rapid review
2020     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 2: use in Belgium
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Pomalidomide (Imnovid®)
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pomalidomide (Pomalyst®) for the treatment of refractory multiple myeloma or relapsed and refractory multiple myeloma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Pomalidomide for multiple myeloma – third line
2017     National Institute for Health and Care Excellence (NICE) Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib. NICE technology appraisal guidance 427
2019     National Institute for Health and Care Excellence (NICE) Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal). NICE technology appraisal guidance 602
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ponatinib (Iclusig) for chronic myeloid leukaemia
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ponatinib (Iclusig®)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ponatinib for chronic myeloid leukaemia or Ph+ acute lymphoblastic leukaemia
2017     National Institute for Health and Care Excellence (NICE) Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia. NICE technology appraisal guidance 451
2022     National Institute for Health and Care Excellence (NICE) Ponesimod for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 767